-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Irritable bowel syndrome (IBS) is one of the most common gut-brain interactions and is characterized by recurrent abdominal pain, altered bowel habits, and bloating without any organic abnormaliti.
Irritable bowel syndrome (IBS) is one of the most common gut-brain interactions and is characterized by recurrent abdominal pain, altered bowel habits, and bloating without any organic abnormaliti.
Digestion
Of the 449,595 participants, 22,338 (0%) were diagnosed with I.
Digestive colon cancer
This study confirms that IBS does not increase the overall risk of cancer compared with the general populati.
This study confirms that IBS does not increase the overall risk of cancer compared with the general populati.
Original source:
Wu, Shansh.
Wu, Shansh.
Et .
Irritable Bowel Syndrome and Long-Term Risk of Cancer: A Prospective Cohort Study Among 5 Million Adults in UK Bioba.
The American Journal of Gastroenterolo.
202 Irritable Bowel Syndrome and Long-Term Risk of Cancer: A Prospective Cohort Study Among 5 Million Adults in UK Bioba.
Leave a Comment